HCP, Inc. (HCP) to Distribute Quarterly Dividend of $0.37 on November 19th

HCP, Inc. (NYSE:HCP) announced a quarterly dividend on Wednesday, October 23rd, RTT News reports. Shareholders of record on Monday, November 4th will be paid a dividend of 0.37 per share by the real estate investment trust on Tuesday, November 19th. This represents a $1.48 annualized dividend and a yield of 3.94%.

Shares of HCP opened at $37.59 on Friday. The business’s 50-day moving average is $35.83 and its two-hundred day moving average is $32.99. The company has a market capitalization of $18.63 billion, a P/E ratio of 20.65, a P/E/G ratio of 7.06 and a beta of 0.23. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.90 and a current ratio of 0.90. HCP has a fifty-two week low of $26.18 and a fifty-two week high of $37.93.

HCP (NYSE:HCP) last announced its quarterly earnings results on Wednesday, July 31st. The real estate investment trust reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.46). The company had revenue of $489.15 million for the quarter, compared to analyst estimates of $444.67 million. HCP had a return on equity of 15.54% and a net margin of 53.57%. HCP’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.45 earnings per share. Analysts forecast that HCP will post 1.75 EPS for the current year.

In related news, COO Thomas Klaritch sold 35,014 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total value of $1,261,204.28. Following the transaction, the chief operating officer now directly owns 230,529 shares of the company’s stock, valued at approximately $8,303,654.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.13% of the company’s stock.

Several equities research analysts have weighed in on the company. Barclays increased their price target on HCP from $37.00 to $39.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Argus raised shares of HCP from a “hold” rating to a “buy” rating in a research note on Tuesday, September 10th. TheStreet raised shares of HCP from a “c+” rating to a “b-” rating in a research note on Friday, August 2nd. ValuEngine lowered shares of HCP from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $35.00 to $38.00 in a research note on Tuesday, October 8th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. HCP currently has an average rating of “Buy” and a consensus target price of $36.10.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Further Reading: Outstanding Shares, Buying and Selling Stocks

Dividend History for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.